Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients

[21] Pérez-Gómez B(2018)The association of weight change in young adulthood and smoking status with risk of prostate cancer recurrence Int J Cancer 142 789-9

[22] Sánchez MJ(2019)The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer World J Urol 37 818-52

[23] Khan KS(2018)Impact of body mass index on oncological outcomes of prostate cancer patients after radical prostatectomy Sci Rep 8 1443-9

[24] Cao Y(2018)Predicting prostate cancer progression as a function of ets-related gene status, race, and obesity in a longitudinal patient cohort Eur Urol Focus 4 66051-7

[25] Ma J(2017)The differential impact of body mass index and the feature of metabolic syndrome on oncological outcomes following different surgical procedures in japanese men with prostate cancer Ann Surg Oncol 24 2877-30.

[26] Hu MB(2017)BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people Oncotarget 8 467-40

[27] Xu H(2019)Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study Cancer 125 460-7

[28] Bai PD(2017)Impact du score de Gleason sur la survie sans récidive biologique après prostatectomie totale pour cancer avec marges chirurgicales positives [Impact of Gleason score on biochemical recurrence free survival after radical prostatectomy with positive surgical margins] Prog Urol 27 243-4

[29] Jiang HW(2017)Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study Urol Oncol 35 748-6

[30] Ding Q(2017)Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression Urol Oncol 35 604-6

[21] Pérez-Gómez B(2018)The association of weight change in young adulthood and smoking status with risk of prostate cancer recurrence Int J Cancer 142 789-9

[22] Sánchez MJ(2019)The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer World J Urol 37 818-52

[23] Khan KS(2018)Impact of body mass index on oncological outcomes of prostate cancer patients after radical prostatectomy Sci Rep 8 1443-9

[24] Cao Y(2018)Predicting prostate cancer progression as a function of ets-related gene status, race, and obesity in a longitudinal patient cohort Eur Urol Focus 4 66051-7

[25] Ma J(2017)The differential impact of body mass index and the feature of metabolic syndrome on oncological outcomes following different surgical procedures in japanese men with prostate cancer Ann Surg Oncol 24 2877-30.

[26] Hu MB(2017)BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people Oncotarget 8 467-40

[27] Xu H(2019)Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study Cancer 125 460-7

[28] Bai PD(2017)Impact du score de Gleason sur la survie sans récidive biologique après prostatectomie totale pour cancer avec marges chirurgicales positives [Impact of Gleason score on biochemical recurrence free survival after radical prostatectomy with positive surgical margins] Prog Urol 27 243-4

[29] Jiang HW(2017)Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study Urol Oncol 35 748-6

[30] Ding Q(2017)Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression Urol Oncol 35 604-6